Claris Bio Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $118M

  • Investors
  • 10

Claris Bio General Information

Description

Developer of a topical formulation technology designed to treat orphan ophthalmic disorders. The company's technology creates a recombinant hepatocyte growth factor that accelerates the healing process, enabling healthcare professionals to get access to noninvasive treatment and patients to recover and stay fit.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 475 Magellan Avenue
  • Half Moon Bay, CA 94019
  • United States
+1 (201)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Corporate Office
  • 475 Magellan Avenue
  • Half Moon Bay, CA 94019
  • United States
+1 (201)

Claris Bio Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Claris Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series B) 24-Jul-2026 $118M Completed Clinical Trials - General
3. Debt - General 22-Sep-2025 Completed Clinical Trials - General
2. Debt - General 07-Mar-2025 $3.3M $57.8M Completed Clinical Trials - General
1. Later Stage VC (Series A) 04-Jan-2024 $54.5M $54.5M Completed Clinical Trials - General
To view Claris Bio’s complete valuation and funding history, request access »

Claris Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B2
Series B1
Series A3
Series A-2 25,292,580 $0.000100 $0.64 $0.64 $0.64 5.48%
Series A-1 39,714,280 $0.000100 $0.44 $0.44 $0.44 8.6%
To view Claris Bio’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Claris Bio Patents

Claris Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026030528-A1 Activated hepatocyte growth factor Pending 01-Aug-2024
WO-2026030518-A1 Methods for improved gene insertion and expression in cell lines Pending 01-Aug-2024
AU-2022272740-A1 Compositions of growth factor for the treatment of eye disease Pending 14-May-2021
AU-2022272740-A9 Compositions of growth factor for the treatment of eye disease Pending 14-May-2021
CA-3218000-A1 Compositions of growth factor for the treatment of eye disease Pending 14-May-2021 A61K38/1825
To view Claris Bio’s complete patent history, request access »

Claris Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Claris Bio Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Adage Capital Management Hedge Fund Minority
ADAR1 Capital Management Hedge Fund Minority
Aisling Capital Venture Capital Minority
Catalio Capital Management Venture Capital Minority
Samsara BioCapital Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

Claris Bio FAQs

  • When was Claris Bio founded?

    Claris Bio was founded in 2018.

  • Where is Claris Bio headquartered?

    Claris Bio is headquartered in Half Moon Bay, CA.

  • What is the size of Claris Bio?

    Claris Bio has 8 total employees.

  • What industry is Claris Bio in?

    Claris Bio’s primary industry is Biotechnology.

  • Is Claris Bio a private or public company?

    Claris Bio is a Private company.

  • What is the current valuation of Claris Bio?

    The current valuation of Claris Bio is .

  • What is Claris Bio’s current revenue?

    The current revenue for Claris Bio is .

  • How much funding has Claris Bio raised over time?

    Claris Bio has raised $178M.

  • Who are Claris Bio’s investors?

    Adage Capital Management, ADAR1 Capital Management, Aisling Capital, Catalio Capital Management, and Samsara BioCapital are 5 of 10 investors who have invested in Claris Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process